New York, NY, United States of America

Alberto Fernandez-Tejada

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • New York City, NY (US) (2020)
  • Logrono, ES (2021)
  • Logroño. la Rioja, ES (2021)
  • New York, NY (US) (2017 - 2023)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Alberto Fernandez-Tejada

Introduction

Alberto Fernandez-Tejada is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of immunology and vaccine development. With a total of nine patents to his name, he has made remarkable strides in the synthesis and application of triterpene saponins.

Latest Patents

Among his latest patents, the invention titled "Triterpene saponins, methods of synthesis and uses thereof" stands out. This invention relates to triterpene glycoside saponin-derived adjuvants, including the synthesis of QS-7, a potent immuno-adjuvant that is significantly less toxic than QS-21. The novel semi-synthetic method provided in this patent facilitates the synthesis of QS-7 and QS-21 analogs, which are crucial for preclinical and clinical evaluations. Another notable patent is "Minimal saponin analogues, synthesis and use thereof," which discloses truncated triterpene saponin analogues and their pharmaceutical compositions. This patent also outlines methods for immunizing subjects using these minimal saponin analogues.

Career Highlights

Alberto has had a distinguished career, working at prestigious institutions such as Memorial Sloan Kettering Cancer Center and the Sloan Kettering Institute for Cancer Research. His work has focused on advancing the understanding and application of

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…